IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden · Delayed Price · Currency is SEK 1.732
-0.032 (-1.81%)
Sep 2, 2026, 5:29 PM CET
IRLAB Therapeutics AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 34.22 | 81.86 | 66.92 | 111.31 | 252.78 | 401.9 |
Cash & Short-Term Investments | 34.22 | 81.86 | 66.92 | 111.31 | 252.78 | 401.9 |
Cash Growth | -36.21% | 22.33% | -39.88% | -55.96% | -37.10% | 45.08% |
Accounts Receivable | 97.89 | - | - | - | 3.32 | 4.47 |
Other Receivables | - | 3.32 | 10.08 | 9.17 | 8.9 | 6.27 |
Receivables | 97.89 | 3.32 | 10.08 | 9.17 | 12.22 | 10.74 |
Prepaid Expenses | - | 2.91 | 2.19 | 2.8 | 3.34 | 2.28 |
Other Current Assets | 0 | 0.38 | 0.37 | 0.31 | 0.35 | 6.52 |
Total Current Assets | 132.11 | 88.47 | 79.56 | 123.59 | 268.68 | 421.44 |
Property, Plant & Equipment | 3.41 | 5.47 | 9.79 | 6.67 | 8.01 | 8.35 |
Other Intangible Assets | 46.86 | 46.86 | 46.86 | 46.86 | 46.86 | 42.4 |
Long-Term Deferred Charges | - | - | - | - | - | 0.26 |
Other Long-Term Assets | 0 | 0 | -0 | - | -0 | -0 |
Total Assets | 182.37 | 140.8 | 136.21 | 177.12 | 323.56 | 472.45 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 5.29 | 9.94 | 10.52 | 10.03 | 12.3 |
Accrued Expenses | - | 14.08 | 11.68 | 14.91 | 13.44 | 5.84 |
Short-Term Debt | 22.4 | 26.42 | 53.47 | - | - | - |
Current Portion of Leases | 1.8 | 3.54 | 3.42 | 2.94 | 3.6 | 3.03 |
Current Unearned Revenue | - | - | - | - | - | 42.58 |
Other Current Liabilities | 61.04 | 60.77 | 21.54 | 8.35 | 5.28 | 5.65 |
Total Current Liabilities | 85.24 | 110.09 | 100.04 | 36.73 | 32.34 | 69.4 |
Long-Term Debt | - | - | - | 24.51 | - | - |
Long-Term Leases | - | - | 3.54 | 0.12 | 0.38 | 3.57 |
Total Liabilities | 85.24 | 110.09 | 103.58 | 61.36 | 32.72 | 72.97 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.7 | 1.7 | 1.04 | 1.04 | 1.04 | 1.04 |
Additional Paid-In Capital | 875.66 | 800.41 | 690.21 | 690.21 | 690.21 | 685.45 |
Retained Earnings | -781.51 | -771.39 | -658.61 | -575.48 | -400.41 | -287 |
Comprehensive Income & Other | 1.28 | - | 0 | - | - | - |
Shareholders' Equity | 97.13 | 30.72 | 32.64 | 115.76 | 290.83 | 399.48 |
Total Liabilities & Equity | 182.37 | 140.8 | 136.21 | 177.12 | 323.56 | 472.45 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 24.2 | 29.95 | 60.42 | 27.57 | 3.98 | 6.6 |
Net Cash (Debt) | 10.02 | 51.91 | 6.5 | 83.74 | 248.8 | 395.3 |
Net Cash Growth | - | 699.06% | -92.24% | -66.34% | -37.06% | 44.23% |
Net Cash Per Share | 0.12 | 0.77 | 0.13 | 1.61 | 4.80 | 7.64 |
Filing Date Shares Outstanding | 148.71 | 84.94 | 51.87 | 51.87 | 51.87 | 51.75 |
Total Common Shares Outstanding | 148.71 | 84.94 | 51.87 | 51.87 | 51.87 | 51.75 |
Working Capital | 46.86 | -21.62 | -20.48 | 86.86 | 236.34 | 352.04 |
Book Value Per Share | 0.65 | 0.36 | 0.63 | 2.23 | 5.61 | 7.72 |
Tangible Book Value | 50.27 | -16.14 | -14.23 | 68.9 | 243.97 | 357.08 |
Tangible Book Value Per Share | 0.34 | -0.19 | -0.27 | 1.33 | 4.70 | 6.90 |
Machinery | - | - | - | 6.82 | 6.53 | 3.65 |
Leasehold Improvements | - | 7.14 | 7.14 | 0.12 | 0.12 | 0.12 |